Inpharma Weekly

, Volume 1537, Issue 1, pp 9–9 | Cite as

Intralesional infliximab is feasible in Crohn's disease

Clinical study
  • 4 Downloads

Keywords

Adverse Event Pilot Study Infliximab Ileal Median Dose 

Copyright information

© Adis International Ltd 2006

Personalised recommendations